Shinichi Hasako - Profile and Investment Details

Investor Profile

Shinichi Hasako is a Venture Capital, Investor based in Tokyo, Tokyo, Japan with a diverse investment portfolio that includes companies such as Theolytics, Harpoon Therapeutics, Werewolf Therapeutics, NextCure, Storm Therapeutics, Axial Biotherapeutics, ORIC Pharmaceuticals, Dren Bio, Arcus Biosciences, Orna Therapeutics, Breakpoint Therapeutics. Over time, Shinichi Hasako has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Shinichi Hasako is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Biotech, Manufacturing, Healthcare, Biotechnology, Health and Hospital Services, Reviews and Recommendations, Medical, Therapeutics, Media and Entertainment, Personal Health, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Shinichi Hasako, as their portfolio suggests a familiarity and interest in this area.

Understanding Shinichi Hasako’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.